Chlorine in PDB 8wts: Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
Enzymatic activity of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
All present enzymatic activity of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor:
3.4.22.69;
Protein crystallography data
The structure of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor, PDB code: 8wts
was solved by
J.Peng,
D.Sun,
X.Ding,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.31 /
1.56
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
98.46,
80.98,
51.34,
90,
115.69,
90
|
R / Rfree (%)
|
17.9 /
20.7
|
Other elements in 8wts:
The structure of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
(pdb code 8wts). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 5 binding sites of Chlorine where determined in the
Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor, PDB code: 8wts:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
Chlorine binding site 1 out
of 5 in 8wts
Go back to
Chlorine Binding Sites List in 8wts
Chlorine binding site 1 out
of 5 in the Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl401
b:44.4
occ:1.00
|
CL2
|
A:XDQ401
|
0.0
|
44.4
|
1.0
|
C25
|
A:XDQ401
|
1.7
|
36.5
|
1.0
|
F26
|
A:XDQ401
|
2.4
|
40.5
|
1.0
|
O24
|
A:XDQ401
|
2.5
|
27.5
|
1.0
|
F27
|
A:XDQ401
|
2.6
|
27.2
|
1.0
|
C22
|
A:XDQ401
|
3.0
|
24.6
|
1.0
|
C31
|
A:XDQ401
|
3.3
|
36.3
|
1.0
|
C23
|
A:XDQ401
|
3.4
|
21.5
|
1.0
|
C32
|
A:XDQ401
|
3.6
|
38.9
|
1.0
|
C
|
A:ARG188
|
3.7
|
30.7
|
1.0
|
CA
|
A:ARG188
|
3.8
|
28.2
|
1.0
|
N
|
A:GLN189
|
3.9
|
28.5
|
1.0
|
C21
|
A:XDQ401
|
3.9
|
26.1
|
1.0
|
CE
|
A:MET165
|
3.9
|
30.1
|
0.5
|
CE
|
A:MET49
|
4.1
|
76.4
|
1.0
|
N
|
A:ARG188
|
4.2
|
23.7
|
1.0
|
O
|
A:ARG188
|
4.2
|
28.6
|
1.0
|
CG
|
A:MET49
|
4.3
|
74.5
|
1.0
|
O33
|
A:XDQ401
|
4.4
|
40.1
|
1.0
|
C19
|
A:XDQ401
|
4.5
|
18.5
|
1.0
|
C
|
A:ASP187
|
4.5
|
23.5
|
1.0
|
SD
|
A:MET49
|
4.6
|
78.5
|
1.0
|
O
|
A:ASP187
|
4.6
|
23.9
|
1.0
|
CA
|
A:GLN189
|
4.7
|
32.8
|
1.0
|
O
|
A:MET49
|
4.8
|
41.6
|
1.0
|
C29
|
A:XDQ401
|
4.8
|
29.6
|
1.0
|
CE
|
A:MET165
|
4.8
|
25.1
|
0.5
|
SD
|
A:MET165
|
4.8
|
34.0
|
0.5
|
CB
|
A:GLN189
|
4.9
|
32.8
|
1.0
|
C20
|
A:XDQ401
|
4.9
|
26.1
|
1.0
|
|
Chlorine binding site 2 out
of 5 in 8wts
Go back to
Chlorine Binding Sites List in 8wts
Chlorine binding site 2 out
of 5 in the Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl404
b:34.7
occ:1.00
|
N
|
A:LYS5
|
3.2
|
19.6
|
1.0
|
CD
|
A:ARG4
|
3.4
|
26.4
|
1.0
|
NH1
|
A:ARG4
|
3.4
|
28.0
|
1.0
|
CB
|
A:LYS5
|
3.7
|
28.0
|
1.0
|
CA
|
A:ARG4
|
3.9
|
20.6
|
1.0
|
CA
|
A:LYS5
|
4.0
|
21.9
|
1.0
|
C
|
A:ARG4
|
4.1
|
17.6
|
1.0
|
CG
|
A:LYS5
|
4.1
|
36.1
|
1.0
|
O
|
A:HOH575
|
4.1
|
34.8
|
1.0
|
CB
|
A:ARG4
|
4.2
|
21.8
|
1.0
|
CZ
|
A:ARG4
|
4.3
|
27.8
|
1.0
|
NE
|
A:ARG4
|
4.4
|
26.3
|
1.0
|
CG
|
A:ARG4
|
4.4
|
21.4
|
1.0
|
O
|
A:LYS5
|
4.5
|
27.0
|
1.0
|
C
|
A:LYS5
|
4.8
|
23.4
|
1.0
|
|
Chlorine binding site 3 out
of 5 in 8wts
Go back to
Chlorine Binding Sites List in 8wts
Chlorine binding site 3 out
of 5 in the Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl405
b:44.6
occ:1.00
|
O
|
A:HOH560
|
2.8
|
26.7
|
1.0
|
N
|
A:LEU287
|
2.9
|
20.6
|
1.0
|
O
|
A:HOH743
|
3.3
|
47.9
|
1.0
|
CB
|
A:LEU286
|
3.4
|
24.2
|
0.5
|
CB
|
A:LEU287
|
3.6
|
21.1
|
1.0
|
CG
|
A:LEU287
|
3.7
|
22.8
|
1.0
|
CA
|
A:LEU286
|
3.7
|
22.3
|
0.5
|
CA
|
A:LEU286
|
3.7
|
22.9
|
0.5
|
C
|
A:LEU286
|
3.8
|
20.1
|
1.0
|
CA
|
A:LEU287
|
3.8
|
20.4
|
1.0
|
CD2
|
A:LEU286
|
3.9
|
26.3
|
0.5
|
CB
|
A:LEU286
|
4.0
|
24.3
|
0.5
|
CD1
|
A:LEU287
|
4.0
|
25.9
|
1.0
|
O
|
A:HOH533
|
4.2
|
40.2
|
1.0
|
O
|
A:LEU287
|
4.2
|
26.5
|
1.0
|
O
|
A:HOH517
|
4.4
|
43.1
|
1.0
|
CG
|
A:LEU286
|
4.5
|
24.5
|
0.5
|
C
|
A:LEU287
|
4.5
|
19.6
|
1.0
|
CG
|
A:LEU286
|
4.6
|
26.3
|
0.5
|
OH
|
A:TYR239
|
4.8
|
22.7
|
1.0
|
CD2
|
A:LEU286
|
4.9
|
25.8
|
0.5
|
O
|
A:LEU286
|
5.0
|
20.4
|
1.0
|
|
Chlorine binding site 4 out
of 5 in 8wts
Go back to
Chlorine Binding Sites List in 8wts
Chlorine binding site 4 out
of 5 in the Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl406
b:76.6
occ:1.00
|
N
|
A:GLN74
|
3.1
|
50.1
|
1.0
|
CB
|
A:GLN74
|
3.2
|
56.5
|
1.0
|
CA
|
A:GLN74
|
3.7
|
47.4
|
1.0
|
C
|
A:VAL73
|
4.1
|
51.5
|
1.0
|
O
|
A:GLN74
|
4.1
|
51.0
|
1.0
|
OE1
|
A:GLN74
|
4.3
|
76.5
|
1.0
|
CA
|
A:VAL73
|
4.3
|
49.3
|
1.0
|
O
|
A:ASN72
|
4.4
|
73.2
|
1.0
|
C
|
A:GLN74
|
4.4
|
48.8
|
1.0
|
CG
|
A:GLN74
|
4.6
|
63.6
|
1.0
|
CD
|
A:GLN74
|
4.9
|
67.5
|
1.0
|
CG1
|
A:VAL73
|
5.0
|
50.9
|
1.0
|
|
Chlorine binding site 5 out
of 5 in 8wts
Go back to
Chlorine Binding Sites List in 8wts
Chlorine binding site 5 out
of 5 in the Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl407
b:36.5
occ:1.00
|
OG1
|
A:THR169
|
2.8
|
26.3
|
1.0
|
N
|
A:ALA194
|
3.2
|
23.5
|
1.0
|
N
|
A:THR169
|
3.3
|
25.0
|
1.0
|
O
|
A:HOH531
|
3.3
|
36.4
|
1.0
|
CD
|
A:PRO168
|
3.5
|
24.3
|
1.0
|
CG2
|
A:THR169
|
3.6
|
27.8
|
1.0
|
CB
|
A:LEU167
|
3.6
|
22.2
|
1.0
|
N
|
A:PRO168
|
3.6
|
25.9
|
1.0
|
CB
|
A:THR169
|
3.6
|
26.7
|
1.0
|
CA
|
A:ALA193
|
3.7
|
26.1
|
1.0
|
CB
|
A:ALA194
|
3.7
|
23.3
|
1.0
|
CB
|
A:ALA193
|
3.9
|
30.4
|
1.0
|
C
|
A:ALA193
|
3.9
|
22.4
|
1.0
|
CA
|
A:THR169
|
4.1
|
27.3
|
1.0
|
C
|
A:LEU167
|
4.1
|
22.4
|
1.0
|
CA
|
A:ALA194
|
4.1
|
22.4
|
1.0
|
C
|
A:PRO168
|
4.1
|
27.3
|
1.0
|
CA
|
A:PRO168
|
4.2
|
26.9
|
1.0
|
CB
|
A:PRO168
|
4.2
|
28.2
|
1.0
|
CG
|
A:PRO168
|
4.3
|
28.9
|
1.0
|
CA
|
A:LEU167
|
4.4
|
21.3
|
1.0
|
CG
|
A:LEU167
|
4.6
|
22.2
|
1.0
|
CD1
|
A:LEU167
|
4.6
|
21.7
|
1.0
|
O
|
A:HOH537
|
4.7
|
30.3
|
1.0
|
O
|
A:ALA194
|
4.8
|
22.9
|
1.0
|
CG2
|
A:VAL171
|
4.8
|
16.9
|
1.0
|
O
|
A:LEU167
|
4.8
|
23.0
|
1.0
|
O
|
A:GLN192
|
4.9
|
23.5
|
1.0
|
CD2
|
A:LEU167
|
5.0
|
25.4
|
1.0
|
C
|
A:ALA194
|
5.0
|
27.5
|
1.0
|
|
Reference:
J.Peng,
D.Sun,
X.Ding.
Sars-Cov-2 3CLPRO Bound to Covalent Inhibitor To Be Published.
Page generated: Sun Jul 13 15:36:32 2025
|